StockData

Aimei Health Technology Co., Ltd. (AFJK) company profile

AFJKNasdaqBlank ChecksFiscal year ends December 31Also trades as AFJKR, AFJKU
Số liệu tài chính tới Q3 năm tài chính 2026, quý kết thúc ngày Sep 30, 2026Last filing: 10-Q on Nov 16, 2026Score 5/30
$11.84−0.27 (-2.23%)

Close on Nov 17, 2026Market cap $37.49MP/E –Yield –

About Aimei Health Technology

Blank Checks, SIC 6770

Aimei Health Technology Co., Ltd. is a blank check company formed for the purpose of effecting a merger, share exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more operating entities. The organization focuses primarily on targeting small-cap businesses within the healthcare landscape, specifically across the biopharmaceutical, medical technology, medical device, and diagnostic or related services sectors. As an acquisition vehicle, it does not manufacture commercial products or deliver consumer services directly to clients or end customers.

The company is incorporated in the Cayman Islands as an exempted company and maintains its principal executive offices in New York, New York. Its operational reach and search efforts for identifying potential business combination candidates are not restricted to any particular geographic location.

Summary of the business section of Aimei Health Technology's latest annual report, written by StockData.

Company profile

Company

Legal name
Aimei Health Technology Co., Ltd.
Founded
2023
Headquarters
New York, NY
Address
10 East 53rd Street, Suite 3001 10022
Phone
34 678 035200
Industry
Blank Checks
Fiscal year ends
December 31
Auditor
MaloneBailey, LLP, Houston, Texas

Stock & identifiers

Ticker
AFJK
Other tickers
AFJKR, AFJKU
Exchange
Nasdaq
IPO date
Dec 5, 2023
Shares outstanding
3M, Aug 13, 2026
Public float
$44.55M, Jun 30, 2025
Filer category
Non-accelerated filer<br>Smaller reporting company<br>Emerging growth company
SEC CIK
1979005
FIGI
BBG01KH0P454
Share class FIGI
BBG01KH0P515
EIN
00-0000000

Executives and directors

Officers and directors who filed ownership reports (Forms 3, 4, 5) in the last two years

NamePositionShares owned
Daniel Veikko PolviDirector–

IPO

From the final prospectus (Form 424B4) and the first day of trading

SPAC offering

Type
SPAC (blank check) IPO of units
Final prospectus filed
Dec 5, 2023
Securities offered
6,000,000
First trading day
Dec 4, 2023
First-day close
$10.15
Lock-up ends (est.)
Jun 1, 2024

Lock-up end is estimated as 180 days after the first trading day; the prospectus sets the actual terms.

Corporate history

Events identified from SEC filings

See a number that looks wrong?